Indomethacin for the treatment of Alzheimer's disease patients. - Wikidata - wikimedia - TriplyDB

Indomethacin for the treatment of Alzheimer's disease patients.

Indomethacin for the treatment of Alzheimer's disease patients.

http://www.wikidata.org/entity/Q34699322

about

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies Testosterone supplementation for mild cognitive impairment and dementia Aspirin and anti-inflammatory drugs for Alzheimer's disease Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial Progress update: Pharmacological treatment of Alzheimer's disease.Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms.

P2860

Q24235107-EE0F8012-6BEB-4BB9-850F-C26CCE502CD5 Q24236199-6DBBE54F-8972-447E-A7AC-62265A5F925B Q24240719-0A3FCDDC-6EC5-4D32-90FF-9D46D95E1166 Q24243604-EA59FF2D-879C-4943-9E5B-9B65F1EF6511 Q33289262-8EB13351-B05F-41AE-B765-64B4EED5BD84 Q35671005-3B972AD4-B6FA-4FC7-837D-8A3CCF2B4857 Q37129735-D48E1CFC-93B5-46DC-813E-69579FF4FB63 Q38663092-4991C860-E080-43FB-951E-7135EE03351B

P2860

Indomethacin for the treatment of Alzheimer's disease patients.

http://www.wikidata.org/entity/Q34699322

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Indomethacin for the treatment of Alzheimer's disease patients.

@ast

Indomethacin for the treatment of Alzheimer's disease patients.

@en

Indomethacin for the treatment of Alzheimer's disease patients.

@nl

type

label

Indomethacin for the treatment of Alzheimer's disease patients.

@ast

Indomethacin for the treatment of Alzheimer's disease patients.

@en

Indomethacin for the treatment of Alzheimer's disease patients.

@nl

prefLabel

Indomethacin for the treatment of Alzheimer's disease patients.

@ast

Indomethacin for the treatment of Alzheimer's disease patients.

@en

Indomethacin for the treatment of Alzheimer's disease patients.

@nl

P1433

Q34699322-0EDFEDB6-0591-4575-9789-9740ECA1093D

P1476

Q34699322-48EAE1B9-2646-4163-BBDC-28DBABA6A410

P2093

Q34699322-052352A7-5AE7-42C9-A561-486B75B984C2

Q34699322-C24C45A2-13EF-4DA0-988E-4EB8AAD73E1B

P2860

Q34699322-14936146-C967-4A2F-91A8-2AB547A801AA

Q34699322-36B24961-3ADA-4240-A994-F4811D96410A

Q34699322-385C79AF-9C26-4D46-BB14-03F64E84BEAA

Q34699322-42E739AA-C932-42FF-ADD4-79350FDADCFD

Q34699322-4A93BED0-4E88-49BA-B404-12AD2F870E11

Q34699322-5B7FFEF4-4A42-4F53-96CC-99756A590193

Q34699322-661C697E-7E5B-4E0A-8983-6BE46A2121C5

Q34699322-8054B82B-745D-4761-A8E1-6099E2EB4F09

Q34699322-937017B0-C247-41A4-9845-5FD01DE66C01

Q34699322-AE7771E9-700E-4957-8DE2-1A7CB62DD7CD

P304

Q34699322-028D2A26-E02B-47F8-9E8C-91B298754329

P31

Q34699322-8872D9A4-4DB9-4F21-A87F-B2439A03589C

P356

Q34699322-8188FD3A-4F41-43FE-BD56-B521F689D85D

P433

Q34699322-8C5B8AA5-A129-457D-AE09-1C59CCA47BFB

P577

Q34699322-B510F100-EB00-4AD0-9632-768B1028C39C

P698

Q34699322-7636089E-E02E-46BE-BFA0-69094F5CFDE0

P921

Q34699322-D5576EB4-CD92-4599-9726-DE092247A152

P932

Q34699322-56E6C972-944E-4203-A557-BF7CD061BFC7

P356

14651858.CD003673

P1433

Cochrane Database of Systematic Reviews

P1476

Indomethacin for the treatment of Alzheimer's disease patients.

@en

P2093

H Feldman

http://www.w3.org/2001/XMLSchema#string

N Tabet

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development.

Anti-inflammatory drugs: a hope for Alzheimer's disease?

Risk of Alzheimer's disease and duration of NSAID use.

Clinical Pharmacokinetics of indomethacin.

Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production.

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies.

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.

Molecular aspects of inflammatory and immune responses in Alzheimer's disease.

Indomethacin reverses the microglial response to amyloid beta-protein.

P304

CD003673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD003673

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12076498

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

6669267

http://www.w3.org/2001/XMLSchema#string